Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dustin Dovala

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Journal of the American Chemical Society|December 9, 2022
An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4Angel Gonzalez-Valero, Audrey G Reeves, Annika C S Page, et al.
ACS Infectious Diseases|June 15, 2021
Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2Scott B Biering, Erik Van Dis, Eddie Wehri, et al.
Journal of Medicinal Chemistry|September 27, 2024
Identification of Potent, Broad-Spectrum Coronavirus Main Protease Inhibitors for Pandemic PreparednessDavid T Barkan, Keira Garland, Lei Zhang, et al.
Nature Chemical Biology|February 25, 2022
Deubiquitinase-targeting chimeras for targeted protein stabilizationNathaniel J Henning, Lydia Boike, Jessica N Spradlin, et al.
Journal of Medicinal Chemistry|February 9, 2026
Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease InhibitorJulien P N Papillon, Jun Yuan, Matthew J Hesse, et al.
Npj Drug Discovery|July 1, 2026
Preclinical characterization of EGT710, an oral non-peptidomimetic reversible covalent SARS-CoV-2 main protease inhibitorStephanie A Moquin, Suresh B Lakshminarayana, Kamal Kumar Balavenkatraman, et al.
Science (New York, N.Y.)|July 4, 2024
A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin inductionPamela Y Ting, Sneha Borikar, John Ryan Kerrigan, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Journal of the American Chemical Society|December 9, 2022
An Activity-Based Oxaziridine Platform for Identifying and Developing Covalent Ligands for Functional Allosteric Methionine Sites: Redox-Dependent Inhibition of Cyclin-Dependent Kinase 4Angel Gonzalez-Valero, Audrey G Reeves, Annika C S Page, et al.
ACS Infectious Diseases|June 15, 2021
Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2Scott B Biering, Erik Van Dis, Eddie Wehri, et al.
Journal of Medicinal Chemistry|September 27, 2024
Identification of Potent, Broad-Spectrum Coronavirus Main Protease Inhibitors for Pandemic PreparednessDavid T Barkan, Keira Garland, Lei Zhang, et al.
Nature Chemical Biology|February 25, 2022
Deubiquitinase-targeting chimeras for targeted protein stabilizationNathaniel J Henning, Lydia Boike, Jessica N Spradlin, et al.
Journal of Medicinal Chemistry|February 9, 2026
Discovery of EGT710, an Oral Nonpeptidomimetic Reversible Covalent SARS-CoV-2 Main Protease InhibitorJulien P N Papillon, Jun Yuan, Matthew J Hesse, et al.
Npj Drug Discovery|July 1, 2026
Preclinical characterization of EGT710, an oral non-peptidomimetic reversible covalent SARS-CoV-2 main protease inhibitorStephanie A Moquin, Suresh B Lakshminarayana, Kamal Kumar Balavenkatraman, et al.
Science (New York, N.Y.)|July 4, 2024
A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin inductionPamela Y Ting, Sneha Borikar, John Ryan Kerrigan, et al.
Pageof 4